Pixium Vision notified of threshold crossing following passive dilution

Paris, 28 September 2020 7:00 am CET Pixium Vision (Euronext Growth Paris - FR0011950641), a bioelectronics company that develops innovative bionic vision systems to enable patients who have lost their sight to live more independently, has been informed by Bpifrance Investissement of a passive crossing of the threshold of 5% of the share capital, following the increase in the total number of shares and voting rights of the Company due to the conversion by L1 Capital of an amount of convertible debt into shares.